REFERENCES
- Ekstrom PA, Tomlinson DR. Impaired nerve regeneration in streptozotocin-diabetic rats in improved by treatment with gang-liosides. Exp Neurol 1990; 109: 200–203
- Feldmen EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuropathy. Clin Neurosci 1997; 4: 365–370
- Gainer H. Cell-specific gene expression in oxytocin and vaso-pressin magnocel I u I ar neurons. Adv Exp Med Biol 1998; 449: 15–27
- Brooks DP, Nutting DF, Crofton JT, et al. Vasporessin in rats with genetic and streptozocin-induced diabtes. Diabetes 1989; 38: 54–57
- Serino R, Ueta Y, Tokunaga M, et al. Upregulation of hypothalamic nitric oxide synthase gene expression in streptozotocin-induced diabetic rats. Diabetogia 1998; 41: 640–648
- Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 1979; 28: 503–508
- Dheen ST, Tay SS, Wong WC. Arginine vasopressin- and oxytocin-like immunoreactive neurons in the hypothalamic paraventricular and supraoptic nuclei of streptozotocin-induced diabetic rats. Arch Histol Cytol 1994; 57: 461–472
- Dheen ST, Tay SS, Wong WC. Ultrastructural changes in the hypothalamic paraventricular nucleus of the streptozotocin-induced diabetic rat. Acta Anat (Basel) 1994; 149: 291–299
- Dheen ST, Tay SS, Wong WC. Ultrastructural changes in the hypothalamic supraoptic nucleus of the streptozotocin-induced diabetic rat. J Anat 1994; 184: 615–623
- Kadowaki K, Kishimoto J, Leng G, et al. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading: Evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology 1994; 134: 1011–1117
- Kang YK, Choo SK, Nam SH. The effect of silkworm-extract on blood components levels in mice. Korean J Entomol 2001; 31: 243–247
- Saravia FE, Gonzalez S, Roig P, et al. Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell Mol Neurobiol 2001; 21: 15–27
- Van Itallie CM, Fernstrom JD. Osmotal effects on vasopressin secretion in the streptozotocin-diabetes rat. Am] Physiol 1982; 242: E411—E417
- Klein JP, Hains BC, Craner MJ, et al. Apoptosis of vasopressinergic hypothalamic neurons in chronic diabetes mellitus. Neurobiol Dis 2004; 15: 221–228
- Li PA, Siesjo BK. Role of hyperglycemia-related acidosis in ischemic brain damage. Acta Physiol Scand 1997; 161: 567–580
- Gisselsson L, Smith ML, Siesjo BK. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metab 1999; 19: 288–297
- Fernstrom J, Fernstrom M, Kwok R. In vivo somatostatin, vasopressin and oxytocin synthesis in diabetic rat hypothalamus. Am] Physiol 1990; 258: E661—E666
- Asano N, Yamashita T, Yasuda K, et al. Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 2001; 49: 4208–4213
- Ryu KS, Lee HS, Chung SH, et al. An activity of lowering blood-glucose levels according to preparative conditions of silkworm powder. Korean] Seric Sci 1997; 39: 79–85
- Hikino H, Mizuno T, Oshima T, et al. Isolation and hypoglycemic activity of moran A, a glycoprotein of Morus alba root barks. Planta Med 1985; 51: 159–160
- Kimura M, Chen FJ, Nakashima N, et al. Antihyperglycemic effects of N-containing sugars derived from mulberry leaves in streptozo-cin-induced diabetic mice. Trad Med 1995; 12: 214–219